Physician

Akta Sehgal Kakodkar, M.D.

According to 2025 Medicare claims, Akta Kakodkar, M.D. (NPI: 1053622928) practices otolaryngology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60540-1105. Kakodkar is affiliated with the Powers Health Partners ACO (ACO ID: A3632), participating under the MSSP model.

Kakodkar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 344 traditional Medicare patients, billed 1,728 HCPCS/CPT codes, and received $83,172 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 382 prescription claims across 186 beneficiaries totaling $6,226 in drug costs, led by Fluticasone Propionate (Fluticasone Propionate). Open Payments data shows 17 records totaling $702. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $43,303 and ending at $83,172. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,386 and ending at $6,226. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	195	495	$43,303
2016	361	1,027	$83,554
2017	484	1,497	$173,737
2018	219	598	$42,583
2019	231	634	$57,566
2020	266	842	$71,351
2021	375	1,624	$117,441
2022	394	1,733	$101,959
2023	399	1,772	$99,742
2024	344	1,728	$83,172

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	106	$5,386
2016	99	277	$7,887
2017	180	524	$15,151
2018	90	273	$6,544
2019	78	170	$5,149
2020	114	283	$8,780
2021	183	374	$9,954
2022	156	346	$8,847
2023	163	375	$12,237
2024	186	382	$6,226

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	89	89	$92
31575	Diagnostic exam of voice box using a flexible endoscope	61	82	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	176	313	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	127	197	$60
69210	Removal of impacted ear wax	88	105	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluticasone Propionate	Fluticasone Propionate	126	6,740	$1,273
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	14	238	$1,198
Ipratropium Bromide	Ipratropium Bromide	39	1,577	$954
Omeprazole	Omeprazole	73	4,014	$445
Pantoprazole Sodium	Pantoprazole Sodium	21	870	$404

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$702	AERIN MEDICAL INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Akta Sehgal Kakodkar, M.D.?

Tedicare shows public-source Medicare data for Akta Sehgal Kakodkar, M.D. (NPI 1053622928), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akta Sehgal Kakodkar, M.D. have ACO affiliation data?

Akta Sehgal Kakodkar, M.D. is shown with ACO affiliation data for Powers Health Partners ACO (MSSP, ACO ID A3632).

What billing organization is linked to Akta Sehgal Kakodkar, M.D.?

Akta Sehgal Kakodkar, M.D. is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Akta Sehgal Kakodkar, M.D. have Open Payments data?

Akta Sehgal Kakodkar, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.